Why this ASX healthcare share is a retiree's dream for FY27

This defensive business is giving investors rising dividends.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The ASX healthcare share Sonic Healthcare Ltd (ASX: SHL) could be one of the best picks within the S&P/ASX 200 Index (ASX: XJO) for retirees wanting dividends.

Sonic Healthcare describes itself as one of the world's leading medical diagnostic companies. It operates in nine countries, including Australia, the UK, Germany, the US, and Switzerland, with 330 laboratories and 47,000 employees. Impressively, it's the number one player in six countries.

For multiple reasons, I think it's a great option for retirees.

Stethoscope with a piggy bank and hundred dollar notes.

Image source: Getty Images

Defensive earnings

Healthcare is a defensive sector because of the nature of the types of services it provides.

People don't choose when to become sick or injured – healthcare demand doesn't change like discretionary spending does. I'd imagine most people (and governments) would prioritise spending on health over most other categories.

Sonic Healthcare provides an essential service in the healthcare process, so I think its earnings are very defensive.

The ASX healthcare share reported an impressive set of numbers in FY26, considering the economic uncertainty.

Revenue grew 13% to $10.9 billion, underlying operating earnings (EBITDA) climbed 11% to $1.9 billion, and underlying earnings per share (EPS) grew 14% to $1.256.

Profit growth is key for a business to deliver a stable and rising dividend because profit pays for passive income. Therefore, even retiree passive income investors need to look at the earnings outlook.

Good dividend credentials

The ASX healthcare share has paid dividends since 1994. It has increased its dividend almost every year since 1994, except in 2011 and 2012, when it maintained it.

There are very few ASX businesses out there that have increased their payout as consistently over the last 25 years.

I expect the business will be able to continue growing its payout for the foreseeable future.

In the 2026 financial year, Sonic Healthcare continued its progressive dividend policy, hiking the payout by 1 cent per share to $1.08. That translates into a dividend yield of 5.4% excluding franking credits and around 7% including franking credits.  

That's a really attractive starting yield for retirees, in my opinion.

The ASX healthcare share has earnings tailwinds

I expect the business will be able to increase its payout in the coming years because its earnings could grow materially.

Demand for its services could grow for the foreseeable future, driven by the ageing and growing population in the company's core markets.

Another way that the company can grow its earnings is by making the occasional acquisition. Its focus in recent times has been Europe. This tactic gives the business a much stronger scale in that market, boosting profit margins.

Over time, I think this business can continue to grow its profits and dividends, making it a compelling pick for investors.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Sonic Healthcare. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A scientist in a white coat and glasses puts her arms in the air in a sign of strength and success.
Healthcare Shares

Why are Telix Pharmaceuticals shares charging higher today?

A key approval is good news for this drug developer.

Read more »

A man holding a cup of coffee puts his thumb up and smiles with a laptop open.
Healthcare Shares

Telix Pharmaceuticals shares: FDA approves Pixclara brain cancer drug

Telix Pharmaceuticals’ US FDA approval for Pixclara is a first for glioma imaging, expanding its precision medicine offerings.

Read more »

Shot of a young scientist looking stressed out while working on a computer in a lab.
Healthcare Shares

CSL shares just fell 5% after a strong rally. Is the recovery losing steam?

Can CSL’s improving outlook justify its higher share price?

Read more »

ASX share investor sitting with a laptop on a desk, pondering something.
Healthcare Shares

Higher or lower: Where are CSL shares going next?

The biotech giant has been on a tear. Is it too late to invest? Let's find out.

Read more »

Doctor with stethoscope holding a tablet and smiling.
Healthcare Shares

ASX healthcare shares are 39% higher since June. Are you missing out?

Healthcare stocks endured a long slump before the sector pivoted three months ago.

Read more »

A sad looking scientist sitting and upset about a share price fall.
Healthcare Shares

EchoIQ shares just crashed 48%. What happens now?

One regulatory letter, half the market cap.

Read more »

young female doctor with digital tablet looking confused.
Healthcare Shares

CSL shares are up 90%. How much higher can they go?

CSL’s recovery could deliver more upside or another sharp reversal.

Read more »

A woman's hair is blown back and her face is in shock at this big news.
Healthcare Shares

Why has this ASX biotech fallen nearly 50% today?

A knockback for a key approval has rocked this company.

Read more »